Innate Pharma SA-Spons ADRIPHA
13F holders, Q4 2024 (December 31)9holders +1
1new positions
0sold out
1famous investor
$1.85avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Innate Pharma SA-Spons ADR (IPHA) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Exchange Traded Concepts, LLC ($143K), Morgan Stanley ($80K) and Citadel Advisors ($22K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Innate Pharma SA-Spons ADR
- CUSIP
- 45781K204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $828 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 920 shares bought and 100,999 shares sold, net −100,079 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Exchange Traded Concepts, LLC | 0.00% | No change | 77,350 | $143K |
| Morgan Stanley | 0.00% | No change | 43,524 | $80K |
| Citadel Advisors | 0.00% | Reduce -44.3% | 11,853 | $22K |
| UBS Group AG | 0.00% | Reduce -58.3% | 3,510 | $6K |
| Rhumbline Advisers | 0.00% | Add +229.3% | 675 | $1K |
| National Bank of Canada | 0.00% | New | 450 | $828 |
| Barclays PLC | 0.00% | No change | 307 | $565 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 200 | $368 |
| Optiver Holding B.V. | 0.00% | Reduce -99.9% | 101 | $187 |
"% of holder's portfolio" is IPHA's weight in each manager's 13F, not the share of Innate Pharma SA-Spons ADR the manager owns.